Z. Dobbie, H. Müller, R. Scott (1996)
Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposisHuman Genetics, 98
Russell Jacoby, Karen Seibert, C. Cole, Gary Kelloff, R. Lubet (2000)
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.Cancer research, 60 18
B. Kennedy, C. Soravia, J. Moffat, L. Xia, T. Hiruki, S. Collins, S. Gallinger, B. Bapat (1998)
Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.Cancer research, 58 3
F. Sinicrope, M. Lemoine, Lixuan Xi, Patrick Lynch, Karen Cleary, Yu Shen, Marsha Frazier (1999)
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.Gastroenterology, 117 2
R. Dubois, S. Abramson, L. Crofford, Rajnish Gupta, L. Simon, L. Putte, P. Lipsky (1998)
Cyclooxygenase in biology and diseaseThe FASEB Journal, 12
B. Reddy, Y. Hirose, R. Lubet, V. Steele, G. Kelloff, Susan Paulson, Karen Seibert, C. Rao (2000)
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.Cancer research, 60 2
N. Arber, H. Hibshoosh, W. Yasui, A. Neugut, A. Hibshoosh, Y. Yao, A. Sgambato, H. Yamamoto, I. Shapira, D. Rosenman, I. Fabian, I. Weinstein, E. Tahara, P. Holt (1999)
Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 8 12
Asif Rashid, S. Hamilton (1997)
Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine.Gastroenterology, 113 1
Jesús Balsinde, M. Balboa, E. Dennis (1998)
Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2.Proceedings of the National Academy of Sciences of the United States of America, 95 14
A. Neugut, J. Jacobson, S. Suh, R. Mukherjee, N. Arber (1998)
The epidemiology of cancer of the small bowel.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 7 3
K. Takaku, M. Sonoshita, N. Sasaki, N. Uozumi, Yoshiko Doi, Takao Shimizu, M. Taketo (2000)
Suppression of Intestinal Polyposis inApc Δ 716 Knockout Mice by an Additional Mutation in the Cytosolic Phospholipase A2Gene*The Journal of Biological Chemistry, 275
W. Karnes, R. Shattuck-Brandt, L. Burgart, R. Dubois, D. Tester, J. Cunningham, C. Kim, S. McDonnell, D. Schaid, S. Thibodeau (1998)
Reduced COX-2 protein in colorectal cancer with defective mismatch repair.Cancer research, 58 23
David Six, E. Dennis (2000)
The expanding superfamily of phospholipase A(2) enzymes: classification and characterization.Biochimica et biophysica acta, 1488 1-2
Karen Hong, Joanna Bonventre, E. O’Leary, J. Bonventre, E. Lander (2001)
Deletion of cytosolic phospholipase A2 suppresses ApcMin-induced tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 98
T. Nevalainen, Grönroos Jm, M. Kallajoki (1995)
Expression of group II phospholipase A2 in the human gastrointestinal tract.Laboratory investigation; a journal of technical methods and pathology, 72 2
M. Oshima, Naomi Hata, S. Kargman, Meztli Arguello, P. Luk, E. Kwong, M. Taketo, Jilly Evans (2001)
Mouse by Rofecoxib , a Specific Cyclooxygenase-2 Inhibitor 716 ∆ Apc Chemoprevention of Intestinal Polyposis in the Updated Version
Oshima (2001)
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitorCancer Res, 61
J. Wheeler, B. Warren, N. Mortensen, H. Kim, S. Biddolph, G. Elia, N. Beck, Geraint Williams, N. Shepherd, A. Bateman, W. Bodmer (2002)
An insight into the genetic pathway of adenocarcinoma of the small intestineGut, 50
C. Eberhart, R. Coffey, A. Radhika, F. Giardiello, S. Ferrenbach, R. Dubois (1994)
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology, 107 4
J. Dimberg, A. Samuelsson, A. Hugander, P. Söderkvist (1998)
Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer.Anticancer research, 18 5A
C. Boland, S. Thibodeau, S. Hamilton, D. Sidransky, J. Eshleman, R. Burt, S. Meltzer, M. Rodriguez-Bigas, R. Fodde, G. Ranzani, S. Srivastava (1998)
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer research, 58 22
G. Steinbach, P. Lynch, R. Phillips, M. Wallace, E. Hawk, G. Gordon, Naoki Wakabayashi, B. Saunders, Yu Shen, T. Fujimura, L. Su, B. Levin, L. Godio, S. Patterson, M. Rodriguez-Bigas, Susan Jester, K. King, M. Schumacher, J. Abbruzzese, R. Dubois, W. Hittelman, Stuart Zimmerman, J. Sherman, G. Kelloff (2000)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.The New England journal of medicine, 342 26
L. Spirio, W. Kutchera, M. Winstead, B. Pearson, C. Kaplan, M. Robertson, E. Lawrence, R. Burt, J. Tischfield, M. Leppert, S. Prescott, R. White (1996)
Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli.Cancer research, 56 5
M. Oshima, J. Dinchuk, S. Kargman, H. Oshima, Bruno Hancock, E. Kwong, J. Trzăskos, Jilly Evans, M. Taketo (1996)
Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 87
R. Cormier, Karen Hong, R. Halberg, T. Hawkins, P. Richardson, R. Mulherkar, W. Dove, E. Lander (1997)
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesisNature Genetics, 17
Lindor (2002)
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumorsJ Clin Oncol, 20
A. Soydan, I. Tavares, P. Weech, N. Temblay, A. Bennett (1996)
High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue.European journal of cancer, 32A 10
S. Pugh, G. Thomas (1994)
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.Gut, 35
M. Murakami, S. Shimbara, T. Kambe, H. Kuwata, M. Winstead, J. Tischfield, I. Kudo (1998)
The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid ReleaseThe Journal of Biological Chemistry, 273
Kouji Watanabe, T. Kawamori, S. Nakatsugi, T. Ohta, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, F. Ushikubi, S. Narumiya, Takashi Sugimura, K. Wakabayashi (1999)
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.Cancer research, 59 20
M. Arai, S. Shimizu, Y. Imai, Y. Nakatsuru, Hideaki Oda, T. Oohara, T. Ishikawa (1997)
Mutations of the Ki‐ras, p53 and APC genes in adenocarcinomas of the human small intestineInternational Journal of Cancer, 70
J. Am, Harman Pk, Hanks Jb (1985)
Primary small bowel malignancies.American Surgeon, 51
H. Sheng, J. Shao, S. Kirkland, P. Isakson, R. Coffey, J. Morrow, R. Beauchamp, R. Dubois (1997)
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.The Journal of clinical investigation, 99 9
X. Hao, A. Bishop, M. Wallace, Hong Wang, T. Willcocks, J. Maclouf, J. Polak, S. Knight, I. Talbot (1999)
Early expression of cyclo‐oxygenase‐2 during sporadic colorectal carcinogenesisThe Journal of Pathology, 187
N. Arber, A. Neugut, I. Weinstein, P. Holt (1997)
Molecular genetics of small bowel cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 6 9
D. Carter (1998)
TNM Classification of Malignant TumorsThe American Journal of Surgical Pathology, 22
Mel MacPhee, K. Chepenik, R. Liddell, K. Nelson, L. Siracusa, A. Buchberg (1995)
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasiaCell, 81
M Haapamäki, J Grönroos, H. Nurmi, K. Alanen, T. Nevalainen (1999)
Gene expression of group II phospholipase A2 in intestine in Crohn's diseaseAmerican Journal of Gastroenterology, 94
MD Sellner (1990)
Investigations on the significance of the adenoma‐carcinoma sequence in the small bowelCancer, 66
M. Sonoshita, K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, S. Narumiya, M. Oshima, M. Taketo (2001)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout miceNature Medicine, 7
N. Lindor, L. Burgart, O. Leontovich, R. Goldberg, J. Cunningham, D. Sargent, C. Walsh-Vockley, G. Petersen, M. Walsh, B. Leggett, Joanne Young, M. Barker, J. Jass, J. Hopper, S. Gallinger, B. Bapat, M. Redston, S. Thibodeau (2002)
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 4
H. Sano, Y. Kawahito, R. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, T. Hla (1995)
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.Cancer research, 55 17
Jesús Balsinde, M. Balboa, P. Insel, E. Dennis (1999)
Regulation and inhibition of phospholipase A2.Annual review of pharmacology and toxicology, 39
Modern Pathology – CrossRef
Published: Feb 1, 2003
Access the full text.
Sign up today, get DeepDyve free for 14 days.